The Δexon14 was detected in 9 of the 61 confirmed MPN patients (15%) (Table 1), where it accounted for 3.96% to 33.85% (mean  = 12.04%) of JAK2 transcript. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.